- FH Optimal Care in the US (FOCUS) Real-World Data Analysis Report – 2018 – The FH Foundation’s FOCUS Report quantifies gaps in diagnosis and treatment, and the unfortunate corresponding cardiovascular event rates in individuals with familial hypercholesterolemia (FH). The FOCUS Report leverages a national healthcare database built by the FH Foundation that includes healthcare encounter data on over 272 million individuals in the United States being treated, or evaluated for, cardiovascular disease. All data is anonymous at the individual level.
- PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers Seth J. Baum, Peter P. Toth, James A. Underberg, Paul Jellinger, Joyce Ross, Katherine Wilemon
- Access to Innovative Medicines Tip Sheet Developed by the Preventive Cardiovascular Nurses Association, this is a critical reference includes tips and resources for how to navigate administrative systems, maximize efficiency of the prior authorization process, and improve nurse job satisfaction and adherence/patient outcomes. Particularly focused on PCSK9, NOAC and new heart failure therapies.